Drug Type Small molecule drug |
Synonyms- |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC15H22N2O |
InChIKeyAAGFPTSOPGCENQ-JLNYLFASSA-N |
CAS Registry6483-15-4 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Cardiomyopathies | Phase 2 | - | - | |
Cardiomyopathies | Phase 2 | - | - | |
Analgesia | Preclinical | CN | 30 Jan 2025 | |
Inflammation | Preclinical | CN | 30 Jan 2025 | |
Pruritus | Preclinical | CN | 30 Jan 2025 |